IW
VRTX icon

Imprint Wealth’s Vertex Pharmaceuticals VRTX Stock Holding History

Imprint Wealth’s Portfolio VRTX Stock Details VRTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$3.13K Hold
7
– – 0.01% 203
2025
Q4 		$3.17K Sell
7
-7
-50% -$3.02K 0.01% 231
2025
Q3 		$5.48K Buy
+14
New +$5.85K 0.02% 240
2024
Q1 		$420K Buy
+999
New +$422K 0.1% 183

Other funds holding VRTX

Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
Capital International Investors
Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return

Imprint Wealth's VRTX Position: Q1 2026 in Review

Imprint Wealth held its Vertex Pharmaceuticals (VRTX) position steady in Q1 2026 at 7 shares worth $3.13K. The position accounts for 0.01% of the portfolio, ranked #203.

Imprint Wealth first reported a position in VRTX in Q1 2024 and has held it in 4 quarters since. The position peaked at $420K in Q1 2024. 1,687 funds tracked by Wall St. Rank hold VRTX as of Q1 2026.

  • Imprint Wealth held 7 shares of Vertex Pharmaceuticals worth $3.13K as of Q1 2026.
  • Imprint Wealth left its Vertex Pharmaceuticals share count unchanged in Q1 2026.
  • Vertex Pharmaceuticals made up 0.01% of Imprint Wealth's portfolio in Q1 2026, its #203 holding.
  • Imprint Wealth first reported a position in Vertex Pharmaceuticals in Q1 2024 and has held it in 4 quarters since.
  • Imprint Wealth's Vertex Pharmaceuticals position peaked at $420K in Q1 2024.
  • 1,687 funds tracked by Wall St. Rank held Vertex Pharmaceuticals as of Q1 2026.

Based on Imprint Wealth's 13F filing for Q1 2026, filed 15 May 2026.